mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.004 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.006 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.006 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |